Table 2.
Pre- vs. post-CT changes in plasma LPM levels.*
| Analyte | Pre-CT | Post-CT | Post- to Pre-CT | ||
|---|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean (%) | r | p | |
| UL10 (nM) | 344 ± 232 | 427 ± 221 | 124 | 0.55 | 0.17 |
| UN10 (nM) | 62 ± 49 | 68 ± 53 | 108 | 0.93 | 0.35 |
| TQ10 (nM) | 406 ± 258 | 495 ± 254 | 122 | 0.63 | 0.16 |
| UN10/TQ10 (%) | 17 ± 0 | 13 ± 0 | 76 | 0.56 | 0.18 |
| tr LUT (ng/ml) | 65 ± 33 | 63 ± 31 | 96 | 0.99 | 0.03 |
| tr ZEA (ng/ml) | 21 ± 10 | 21 ± 10 | 97 | 0.99 | 0.09 |
| Tot. tr LUT/ZEA (ng/ml) | 87 ± 42 | 83 ± 40 | 96 | 0.99 | 0.03 |
| Tot. cis LUT/ZEA (ng/ml) | 44 ± 22 | 44 ± 22 | 99 | 0.99 | 0.46 |
| tr AH-LUT (ng/ml) | 29 ± 15 | 27 ± 14 | 95 | 0.99 | 0.01 |
| cis AH-LUT (ng/ml) | 18 ± 10 | 17 ± 9 | 96 | 0.99 | 0.10 |
| αCRX (ng/ml) | 18 ± 8 | 17 ± 8 | 95 | 0.98 | 0.047 |
| tr βCRX (ng/ml) | 103 ± 86 | 96 ± 78 | 92 | 0.99 | 0.02 |
| cis βCRX (ng/ml) | 28 ± 20 | 27 ± 19 | 97 | 0.97 | 0.54 |
| Tot. LYCOP (ng/ml) | 395 ± 308 | 365 ± 273 | 92 | 0.99 | 0.03 |
| tr LYC (ng/ml) | 119 ± 89 | 111 ± 83 | 93 | 0.99 | 0.02 |
| 5 cis lyc (ng/ml) | 183 ± 158 | 167 ± 138 | 92 | 0.99 | 0.03 |
| DHLYC (ng/ml) | 93 ± 72 | 87 ± 63 | 93 | 0.99 | 0.06 |
| αCAR (ng/ml) | 32 ± 32 | 30 ± 31 | 94 | 0.99 | 0.04 |
| tr βCAR (ng/ml) | 126 ± 73 | 116 ± 68 | 92 | 0.99 | 0.01 |
| cis βCAR (ng/ml) | 10 ± 7 | 8 ± 4 | 82 | 0.72 | 0.15 |
| Tot. βCAR (ng/ml) | 136 ± 78 | 124 ± 72 | 92 | 0.98 | 0.01 |
| Tot. CAROT (ng/ml) | 890 ± 473 | 831 ± 428 | 93 | 0.99 | 0.004 |
| δTOC (ng/ml) | 519 ± 35 | 506 ± 38 | 97 | 0.59 | 0.12 |
| β + γTOC (ng/ml) | 1256 ± 533 | 1181 ± 464 | 94 | 0.97 | 0.04 |
| αTOC (ng/ml) | 7675 ± 2334 | 7218 ± 2149 | 94 | 0.97 | 0.01 |
| Tot. TOC (ng/ml) | 9450 ± 2452 | 8904 ± 2217 | 94 | 0.96 | 0.005 |
| tr RET (ng/ml) | 294 ± 88 | 285 ± 93 | 97 | 0.96 | 0.19 |
The bolded values signifies statistical significance (i.e. p < 0.05) between pre-CT and post-CT values.
*
n = 17 children.